Ocuphire Pharma (OCUP) Stock Climbs On Clinical Data

Ocuphire Pharma OCUP Stock News

Ocuphire Pharma Inc (NASDAQ: OCUP) is screaming for the top in the market this morning, and for good reason. The company announced positive results from a Phase 2 clinical trial of Nyxol in combination with low-dose pilocarpine. Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! OCUP Stock … Read more